As of 2023 year-end, the firm had $1.2 billion of debt, $1.6 billion of cash and cash equivalents, and $1.5 billion of deferred taxes that are largely related to its Sartorius investment. We forecast ...

Narrow-moat-rated Repligen is a leading provider of bioprocessing solutions for companies that manufacture biologic drugs. Its business lines include advanced filtration and fluid management systems ...

Agriculture minister Atchannaidu holds a teleconference with veterinary officials of East and West Godavari, Krishna and NTR ...

The Arkansas Women's Hall of Fame (AWHOF) is seeking nominations for the 2025 Induction Class.

For more information about the conference, visit bcic.bio.org About CNS Pharmaceuticals, Inc. CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer ...

Access to the live webcasts of these events, as well as archived recordings, will be available under the “Events” tab on the investor relations section of the SAB BIO website at https://ir.sab ...

MIAMI, Jan. 31, 2025 (GLOBE NEWSWIRE) -- SAB BIO (Nasdaq: SABS), (“SAB BIO ... team will participate in the following investor conferences: Event: Guggenheim SMID Cap Biotech Conference ...

2025 at the Oppenheimer 35th Annual Healthcare Life Sciences Conference. A webcast of the presentation will be available on the Events and Presentations page of Q32 Bio's website at www.q32bio.com.

CARMIEL, Israel, Feb. 4, 2025 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American:PLX), a biopharmaceutical company focused on the development, production and commercialization of ...

SAB BIO (SAB) is a clinical-stage biopharmaceutical company focused on developing human, multi- targeted, high-potency immunoglobulins (IgGs), without the need for human donors or convalescent plasma, ...